- 01
Novartis AG
NOVNSIX SuisseSuisse
$286 Milliards
+3.1% 1W·+14.6% 1Y
- 02
AstraZeneca PLC
AZNNew YorkRoyaume-Uni
$257 Milliards
— 1W·-3.2% 1Y
- 03
Thermo Fisher Scientific Inc.
TMONew YorkÉtats-Unis
$255 Milliards
+3.7% 1W·+28.0% 1Y
- 04
Kite Pharma (Gilead Sciences)
GILDNasdaqÉtats-Unis
$194 Milliards
+5.8% 1W·+27.2% 1Y
- 05
Vertex Pharmaceuticals Inc.
VRTXNasdaqÉtats-Unis
$127 Milliards
+6.1% 1W·+19.9% 1Y
- 06
Bristol-Myers Squibb Company (BMS)
BMYNew YorkÉtats-Unis
$122 Milliards
+8.8% 1W·+37.0% 1Y
- 07
WuXi AppTec Co., Ltd.
02359Hong KongChine
$75.9 Milliards
-5.5% 1W·+93.5% 1Y
- 08
Boston Scientific
BSXNew YorkÉtats-Unis
$64.3 Milliards
+5.2% 1W·-55.3% 1Y
- 09
Lonza Group AG
LONNSIX SuisseSuisse
$51.2 Milliards
+5.8% 1W·+5.0% 1Y
- 10
GenScript Biotech Corporation
1548Hong KongChine
$9.7 Milliards
-3.5% 1W·+109.0% 1Y
- 11
Legend Biotech Corporation
LEGNNasdaqÉtats-Unis
$3.6 Milliards
+6.3% 1W·-42.2% 1Y
- 12
Sarepta Therapeutics Inc.
SRPTNasdaqÉtats-Unis
$1.8 Milliards
+16.1% 1W·-24.0% 1Y
Affichage de 1–12 sur 12